Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
OBJECTIVE: To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 µg/day with chlorofluorocarbon (CFC)-BDP 1500 µg/day.
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2004/823084 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832561159828406272 |
---|---|
author | Louis-Philippe Boulet André Cartier Pierre Ernst Pierre Larivée Michel Laviolette |
author_facet | Louis-Philippe Boulet André Cartier Pierre Ernst Pierre Larivée Michel Laviolette |
author_sort | Louis-Philippe Boulet |
collection | DOAJ |
description | OBJECTIVE: To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 µg/day with chlorofluorocarbon (CFC)-BDP 1500 µg/day. |
format | Article |
id | doaj-art-909d3e2c7f9f40299b83ab7761b2170d |
institution | Kabale University |
issn | 1198-2241 |
language | English |
publishDate | 2004-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Respiratory Journal |
spelling | doaj-art-909d3e2c7f9f40299b83ab7761b2170d2025-02-03T01:25:44ZengWileyCanadian Respiratory Journal1198-22412004-01-0111212313010.1155/2004/823084Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six MonthsLouis-Philippe Boulet0André Cartier1Pierre Ernst2Pierre Larivée3Michel Laviolette4Institut universitaire de cardiologie et de pneumologie, l’Université Laval, Hôpital Laval, Sainte-Foy, Quebec, CanadaService de pneumologie, Hôpital du Sacré-Coeur, Montreal, Quebec, CanadaHôpital Général de Montréal, Montreal, Quebec, CanadaCentre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, CanadaInstitut universitaire de cardiologie et de pneumologie, l’Université Laval, Hôpital Laval, Sainte-Foy, Quebec, CanadaOBJECTIVE: To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 µg/day with chlorofluorocarbon (CFC)-BDP 1500 µg/day.http://dx.doi.org/10.1155/2004/823084 |
spellingShingle | Louis-Philippe Boulet André Cartier Pierre Ernst Pierre Larivée Michel Laviolette Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months Canadian Respiratory Journal |
title | Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months |
title_full | Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months |
title_fullStr | Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months |
title_full_unstemmed | Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months |
title_short | Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months |
title_sort | safety and efficacy of hfa 134a beclomethasone dipropionate extra fine aerosol over six months |
url | http://dx.doi.org/10.1155/2004/823084 |
work_keys_str_mv | AT louisphilippeboulet safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths AT andrecartier safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths AT pierreernst safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths AT pierrelarivee safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths AT michellaviolette safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths |